Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polypill Strategy in Secondary Cardiovascular Prevention.

The New England journal of medicine·2022
Same author

What can heart failure trialists learn from oncology trialists?

European heart journal·2021
Same author

Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study.

Clinical cardiology·2020
Same author

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure.

Circulation·2018
Same author

Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.

International journal of cardiology·2018
Same author

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).

The American journal of cardiology·2018

Related Experiment Video

Updated: May 13, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

International differences in treatment effect: do they really exist and why?

Stuart Pocock1, Gonzalo Calvo, Jaume Marrugat

  • 1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

European Heart Journal
|March 12, 2013
PubMed
Summary

Investigating geographic differences in clinical trial treatment effects is crucial. However, apparent variations often result from chance, requiring cautious interpretation of trial data.

Keywords:
Geographic differencesRandomized clinical trialsSubgroup analysis

More Related Videos

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Related Experiment Videos

Last Updated: May 13, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Global Health

Background:

  • Globalization of clinical trials presents opportunities to analyze geographic treatment effect variations.
  • International differences in patient selection, medical practice, and outcome evaluation can influence treatment effects.
  • Lack of documentation for geographic variations in trial reports hinders comprehensive analysis.

Purpose of the Study:

  • To highlight the importance of exploring potential geographic differences in treatment effects within global clinical trials.
  • To emphasize the need for appropriate statistical analyses, including interaction tests, for geographic heterogeneity.
  • To caution against over-interpretation of apparent geographic inconsistencies in treatment effects.

Main Methods:

  • Reviewing key examples like the PLATO and MERIT-HF trials.
  • Discussing the challenges of geographic subgroup analyses, including limited statistical power.
  • Advocating for pre-defined statistical analyses to assess geographic treatment effect variations.

Main Results:

  • Geographic variations in treatment effect are often hypothesis-generating rather than definitive.
  • Apparent geographic inconsistencies can arise from the play of chance.
  • Statistical power for detecting geographic heterogeneity is typically limited.

Conclusions:

  • Caution is essential when interpreting evidence of geographic inconsistencies in treatment effects.
  • While exploring biological or practical reasons for anomalies is appropriate, chance is often the most likely explanation.
  • Improved documentation of international variations in trial reports is needed.